Citadel Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.8M | Sell |
101,100
-144,700
| -59% | -$72.8M | 0.01% | 1405 |
|
|
2025
Q4 | $115M | Buy |
245,800
+51,600
| +27% | +$24M | 0.02% | 773 |
|
|
2025
Q3 | $82.8M | Buy |
194,200
+79,000
| +69% | +$30.6M | 0.01% | 982 |
|
|
2025
Q2 | $44.1M | Sell |
115,200
-3,700
| -3% | -$1.33M | 0.01% | 1334 |
|
|
2025
Q1 | $41.1M | Sell |
118,900
-106,800
| -47% | -$34.3M | 0.01% | 1310 |
|
|
2024
Q4 | $67.7M | Buy |
225,700
+62,200
| +38% | +$21.7M | 0.01% | 1013 |
|
|
2024
Q3 | $66.5M | Sell |
163,500
-53,400
| -25% | -$19.6M | 0.01% | 988 |
|
|
2024
Q2 | $69.7M | Buy |
216,900
+39,700
| +22% | +$12.9M | 0.01% | 892 |
|
|
2024
Q1 | $59.1M | Sell |
177,200
-30,900
| -15% | -$9.44M | 0.01% | 1073 |
|
|
2023
Q4 | $56.3M | Sell |
208,100
-29,600
| -12% | -$7.32M | 0.01% | 1089 |
|
|
2023
Q3 | $58.5M | Buy |
237,700
+98,900
| +71% | +$27.1M | 0.01% | 950 |
|
|
2023
Q2 | $42.1M | Sell |
138,800
-179,400
| -56% | -$49.9M | 0.01% | 1186 |
|
|
2023
Q1 | $83.9M | Buy |
318,200
+124,300
| +64% | +$31.6M | 0.02% | 717 |
|
|
2022
Q4 | $46.5M | Sell |
193,900
-118,800
| -38% | -$26.6M | 0.01% | 1178 |
|
|
2022
Q3 | $57.5M | Buy |
312,700
+141,400
| +83% | +$28.2M | 0.01% | 955 |
|
|
2022
Q2 | $28.8M | Sell |
171,300
-45,200
| -21% | -$9.71M | 0.01% | 1501 |
|
|
2022
Q1 | $54.3M | Sell |
216,500
-26,100
| -11% | -$6.55M | 0.01% | 1061 |
|
|
2021
Q4 | $62.3M | Buy |
242,600
+9,600
| +4% | +$2.35M | 0.01% | 997 |
|
|
2021
Q3 | $56.6M | Sell |
233,000
-10,600
| -4% | -$2.59M | 0.01% | 1032 |
|
|
2021
Q2 | $50.4M | Sell |
243,600
-89,200
| -27% | -$18.2M | 0.01% | 1118 |
|
|
2021
Q1 | $62.7M | Buy |
332,800
+196,600
| +144% | +$34.7M | 0.02% | 863 |
|
|
2020
Q4 | $22.4M | Sell |
136,200
-175,200
| -56% | -$25.6M | 0.01% | 1680 |
|
|
2020
Q3 | $38.8M | Buy |
311,400
+73,900
| +31% | +$9.15M | 0.01% | 1026 |
|
|
2020
Q2 | $23.1M | Buy |
237,500
+50,500
| +27% | +$5.25M | 0.01% | 1395 |
|
|
2020
Q1 | $16.8M | Sell |
187,000
-18,100
| -9% | -$2.34M | 0.01% | 1372 |
|
|
2019
Q4 | $30.3M | Buy |
205,100
+88,300
| +76% | +$11.9M | 0.01% | 1115 |
|
|
2019
Q3 | $14.1M | Sell |
116,800
-7,100
| -6% | -$918K | 0.01% | 1840 |
|
|
2019
Q2 | $16.7M | Buy |
123,900
+31,000
| +33% | +$3.92M | 0.01% | 1601 |
|
|
2019
Q1 | $12.1M | Sell |
92,900
-8,400
| -8% | -$1.13M | 0.01% | 1843 |
|
|
2018
Q4 | $12.6M | Buy |
101,300
+23,400
| +30% | +$3.14M | 0.01% | 1649 |
|
|
2018
Q3 | $10.8M | Sell |
77,900
-8,000
| -9% | -$996K | ﹤0.01% | 2000 |
|
|
2018
Q2 | $8.81M | Buy |
85,900
+10,000
| +13% | +$1.01M | ﹤0.01% | 2075 |
|
|
2018
Q1 | $7.36M | Sell |
75,900
-5,300
| -7% | -$514K | ﹤0.01% | 2034 |
|
|
2017
Q4 | $7.13M | Buy |
81,200
+4,300
| +6% | +$345K | ﹤0.01% | 2068 |
|
|
2017
Q3 | $6.12M | Buy |
76,900
+29,800
| +63% | +$2.4M | ﹤0.01% | 2092 |
|
|
2017
Q2 | $4.11M | Sell |
47,100
-32,400
| -41% | -$2.74M | ﹤0.01% | 2333 |
|
|
2017
Q1 | $7.08M | Buy |
79,500
+14,800
| +23% | +$1.23M | 0.01% | 1698 |
|
|
2016
Q4 | $4.79M | Sell |
64,700
-136,500
| -68% | -$10.2M | ﹤0.01% | 2053 |
|
|
2016
Q3 | $15.2M | Buy |
201,200
+156,400
| +349% | +$12M | 0.02% | 1039 |
|
|
2016
Q2 | $3.45M | Sell |
44,800
-23,700
| -35% | -$1.87M | ﹤0.01% | 2168 |
|
|
2016
Q1 | $5.35M | Sell |
68,500
-28,500
| -29% | -$1.99M | 0.01% | 1698 |
|
|
2015
Q4 | $6.56M | Sell |
97,000
-33,100
| -25% | -$2.31M | 0.01% | 1585 |
|
|
2015
Q3 | $10.1M | Sell |
130,100
-211,100
| -62% | -$18.7M | 0.01% | 1354 |
|
|
2015
Q2 | $31M | Buy |
341,200
+197,500
| +137% | +$15.8M | 0.03% | 747 |
|
|
2015
Q1 | $10.8M | Buy |
143,700
+40,200
| +39% | +$2.89M | 0.01% | 1382 |
|
|
2014
Q4 | $7.6M | Buy |
103,500
+17,400
| +20% | +$1.22M | 0.01% | 1621 |
|
|
2014
Q3 | $6.07M | Sell |
86,100
-61,000
| -41% | -$4.03M | 0.01% | 1818 |
|
|
2014
Q2 | $8.29M | Buy |
147,100
+96,600
| +191% | +$5.1M | 0.01% | 1413 |
|
|
2014
Q1 | $2.65M | Buy |
50,500
+3,200
| +7% | +$159K | ﹤0.01% | 2356 |
|
|
2013
Q4 | $2.26M | Sell |
47,300
-1,000
| -2% | -$46.2K | ﹤0.01% | 2420 |
|
|
2013
Q3 | $2.06M | Sell |
48,300
-22,700
| -32% | -$887K | ﹤0.01% | 2388 |
|
|
2013
Q2 | $2.56M | Buy |
+71,000
| New | +$2.75M | ﹤0.01% | 2234 |
|
Other funds holding HCA
VCM
VPM
Citadel Advisors's HCA Position: Q1 2026 in Review
Citadel Advisors reduced its HCA Healthcare (HCA) stake by 24% in Q1 2026, selling an estimated $41.7M and leaving 258,709 shares worth $122M. The position accounts for 0.02% of the portfolio, ranked #690.
Citadel Advisors first reported a position in HCA in Q2 2013 and has held it in 47 quarters since. The position peaked at $317M in Q4 2019. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Citadel Advisors held 258,709 shares of HCA Healthcare worth $122M as of Q1 2026.
- Citadel Advisors sold 82,751 HCA Healthcare shares in Q1 2026, an estimated $41.7M.
- HCA Healthcare made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #690 holding.
- Citadel Advisors first reported a position in HCA Healthcare in Q2 2013 and has held it in 47 quarters since.
- Citadel Advisors's HCA Healthcare position peaked at $317M in Q4 2019.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.